Galmed Pharmaceuticals Ltd. (GLMD) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.95M | -1.94M | -1.27M | -1.17M | -1.97M | -1.06M | -1.02M | -1.83M | -898K | -2.18M | -1.37M | -1.7M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 1.22% | -81.86% | -24.68% | 36.23% | -119.27% | 51.13% | 25.6% | -7.96% | 77.68% | 30.09% | 76.87% | 68.91% |
| Net Income | -4.82M | -1.89M | -2.5M | -1.1M | -3.21M | -1.91M | -1.12M | -1.27M | -2.02M | -1.47M | -1.59M | -1.83M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 74K | 9K | 6K | 8K | 9K | 8K |
| Stock-Based Compensation | 240K | 105K | 100K | 101K | 116K | 132K | 130K | 153K | 195K | 226K | 174K | 297K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 488K | 86K | -317K | 0 |
| Other Non-Cash Items | 2.14M | -83K | 499K | -23K | 1.7M | 49K | -10K | 1K | -564K | 3K | 158K | -134K |
| Working Capital Changes | 490K | -65K | 628K | -141K | -580K | 669K | -92K | -718K | 993K | -1.03M | 202K | -36K |
| Change in Receivables | 117K | -116K | 14K | 225K | -246K | -291K | 119K | 226K | 290K | -429K | 227K | 257K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 429K | -227K | -257K |
| Change in Payables | 329K | 305K | 61K | 0 | -34K | 139K | -180K | -496K | 405K | -666K | -126K | -294K |
| Cash from Investing | 1.43M | -3K | -4.57M | -231K | -3.55M | 614K | 1.39M | 432K | 2.28M | -3.54M | 705K | 1.35M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | -250K | 0 | 0 | 0 | 3.4M | 0 | -1.5M | 1.35K |
| Cash from Financing | 1.19M | 289K | 6.04M | 1.51M | 448K | 8.34M | 0 | 0 | 0 | 6.18M | 0 | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 1.19M | 289K | 6.04M | 1.51M | 4.85M | 0 | 0 | 0 | 0 | 6.18M | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | -4.4M | 8.34M | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 671K | -1.65M | 198K | 116K | -5.07M | 7.89M | 375K | -1.4M | 1.38M | 473K | -662K | -344K |
| Free Cash Flow | -1.95M | -1.94M | -1.27M | -1.17M | -1.97M | -1.06M | -1.02M | -1.83M | -898K | -2.18M | -1.37M | -1.7M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 1.22% | -81.86% | -24.68% | 36.23% | -119.27% | 51.13% | 25.6% | -7.96% | 77.69% | 30.09% | 76.89% | 68.91% |
| FCF per Share | -0.30 | -0.35 | -0.32 | -0.66 | -1.23 | -15.39 | -1.94 | -0.34 | -0.18 | -0.35 | -0.81 | -1.01 |
| FCF Conversion (FCF/Net Income) | 0.40x | 1.02x | 0.51x | 1.06x | 0.61x | 0.56x | 0.91x | 1.44x | 0.45x | 1.48x | 0.86x | 0.93x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |